Member Info for Sangijuelas1

Woodford

Not complaining, I like under the radar.

Talk about under the radar

https://www.londonstockexchange.com/news-article/XSG/agreements-to-trial-domestic-xfiltra/15046514

Seller seems to be done

Wakey

I don't see how they can sell much in Europe if they can't get on this list

https://covid-19-diagnostics.jrc.ec.europa.eu/

Yenom they are probably the same tests but with shorter swabs.

All the school testing in the trials is AN not NP. They have been using Innova as AN where it is difficult to tickle the brain.

They don't give a ****

Hi

As an investor I am a bit concerned that AffiDX is still not on the Covid In Vitro Diagnostics Devices List maintained by the EU authorities.

Given the RNS stating that the device has been registered in the EU for commercialisation, do you know why this is?

This is the database I am talking about.

https://covid-19-diagnostics.jrc.ec.europa.eu/

The EU will be using LFTs as part of it's Digital Covid Certificate to facilitate free movement.

We need to get on the Common List for Rapid Antigen Tests the next time it is updated.

I think the whole country is being sold out to the Chinese.

Yesterday the chancellor of the exchequer was saying he has abandoned seeking equivalence with EU financial services regulations, many of which the FCA proposed when we were a member.

Instead we are now going to do deals with China.!

Orient Gene is the one they are using for the school trials. Rather than Innova.

These trials are seen to be quite controversial so good not to be involved.
e. g. They are calling them trials but there is no informed consent involved, and many parents are complaining that their kids are being used as guinea pigs

You are really busy working in biotech as you say. Yet you get up first thing to read the Avacta share chat.

By the way you are trying too hard.

There are various affimer patents filed at different times with different expiry dates

With regard to Leeds they either paid to use the Affimers in their research or Avacta let them have them for free as their contribution.

If the Leeds work is commercially viable they may want to look at developing it further with Avacta, given the existing connections, rather than with another company. Or maybe a joint venture?

https://biologicalsciences.leeds.ac.uk/biological-sciences/news/article/168/novel-binding-molecules-for-bio-reagents-diagnostics-and-therapeutics-impact-case-study

They want to cover up the number of cases so as not to derail the Great Freedom Day

Well there's 9m riding on it as well as 8m for each additional candidate Point use it for plus royalties and future licensing share by Point

Should start trading on US market today after merging with a SPAC

This link shows how they are using Avacta's preCISION tech.

https://www.pointbiopharma.com/products/tme-technology

Wonder what LFTs they are using?

Most teams at the Olympics will be using LFTs and false positives would be a big problem. They need the best

When they said APAC Japan sprang to mind.

Neutronic, it really seems you aren't paying attention. Every case is another chance for a mutation to emerge. The more cases, the more mutations and the greater the potential for a strain that wipes the floor with the vaccines.

Maybe try finding some sources beyond the Mail and the Telegraph, which is where this ignorance seems to be being promoted.

The bot that hacked a dormant LSE account craves attention. Best not to give it.

I don't think Windbag is much of a hacker